Cerebrovascular Disease in COVID-19

Michael F. Goldberg; Morton F. Goldberg; R. Cerejo; A. H. Tayal

doi:10.3174/AJNR.A6588

Cerebrovascular Disease in COVID-19

Michael F. Goldberg, Morton F. Goldberg, R. Cerejo, A. H. Tayal

School of Medicine

Research output: Contribution to journal › Article › peer-review

52 Scopus citations

Abstract

Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease.

Original language	English (US)
Pages (from-to)	1170-1172
Number of pages	3
Journal	American Journal of Neuroradiology
Volume	41
Issue number	7
DOIs	https://doi.org/10.3174/AJNR.A6588
State	Published - Jul 1 2020

Keywords

ACA anterior cerebral artery
ACE2 angiotensin converting enzyme 2
COVID-19 coronavirus disease 19
SARS-CoV-2 Severe Acute Respiratory Syndrome coronavirus-2

ASJC Scopus subject areas

Clinical Neurology
Radiology Nuclear Medicine and imaging

Access to Document

10.3174/AJNR.A6588

Cite this

@article{83cb5dd845ba4957afdb2f672c40fc2b,

title = "Cerebrovascular Disease in COVID-19",

abstract = "Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease.",

keywords = "ACA anterior cerebral artery, ACE2 angiotensin converting enzyme 2, COVID-19 coronavirus disease 19, SARS-CoV-2 Severe Acute Respiratory Syndrome coronavirus-2",

author = "Goldberg, {Michael F.} and Goldberg, {Morton F.} and R. Cerejo and Tayal, {A. H.}",

year = "2020",

month = jul,

day = "1",

doi = "10.3174/AJNR.A6588",

language = "English (US)",

volume = "41",

pages = "1170--1172",

journal = "American Journal of Neuroradiology",

issn = "0195-6108",

publisher = "American Society of Neuroradiology",

number = "7",

}

TY - JOUR

T1 - Cerebrovascular Disease in COVID-19

AU - Goldberg, Michael F.

AU - Goldberg, Morton F.

AU - Cerejo, R.

AU - Tayal, A. H.

PY - 2020/7/1

Y1 - 2020/7/1

N2 - Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease.

AB - Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease.

KW - ACA anterior cerebral artery

KW - ACE2 angiotensin converting enzyme 2

KW - COVID-19 coronavirus disease 19

KW - SARS-CoV-2 Severe Acute Respiratory Syndrome coronavirus-2

UR - http://www.scopus.com/inward/record.url?scp=85086882221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086882221&partnerID=8YFLogxK

U2 - 10.3174/AJNR.A6588

DO - 10.3174/AJNR.A6588

M3 - Article

C2 - 32409316

AN - SCOPUS:85086882221

SN - 0195-6108

VL - 41

SP - 1170

EP - 1172

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

IS - 7

ER -

Cerebrovascular Disease in COVID-19

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this